Future of e-Cigarettes in Brazil: Anvisa's Public Meeting

Nov.24.2023
Future of e-Cigarettes in Brazil: Anvisa's Public Meeting
Brazil's health regulator, Anvisa, will hold a public meeting on December 1 to discuss the future development of e-cigarettes.

According to Brazilian media outlet Odia, the National Health Surveillance Agency of Brazil (Anvisa) is set to hold a public meeting next Friday (December 1st) to discuss the future development of e-cigarettes in the country.


The e-cigarette has been banned in Brazil since 2009 due to a decree issued by Anvisa. However, currently, the regulatory agency's decision is under review.


In Brazil, despite a ban, the usage of e-cigarettes has continued to grow, with the number of consumers steadily increasing. According to a survey conducted by Ipec in 2022, there are approximately 2.2 million regular users of e-cigarettes in Brazil, all of whom are operating within an illegal market where the source of raw materials and associated risks cannot be determined.


The President of the Information Council for Reducing Smoking Hazards (Direta), Alexandro Lucian, has emphasized the importance of regulations in ensuring consumer safety.


A study, commissioned by the UK government and published in 2022 by King's College London, has reviewed over 400 scientific papers, revealing that e-cigarettes are 95% less harmful than traditional cigarettes. It is worth noting that research on e-cigarettes is prohibited in Brazil.


On the day of the Anvisa meeting, a consumer protest was planned with the aim of exerting pressure on authorities for adequate and safe regulation of e-cigarettes.


According to Lucian, the presence of consumers in this democratic dialogue environment is of utmost significance.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Advocacy Groups Launch "20IsPlenty" Campaign for Nicotine Pouch Strength Limit of 20mg
UK Advocacy Groups Launch "20IsPlenty" Campaign for Nicotine Pouch Strength Limit of 20mg
UK harm reduction groups led by We Vape have launched the “20IsPlenty” campaign calling for a 20mg nicotine pouch cap, a ban on youth advertising, and evidence-based regulation. The initiative coincides with the Tobacco and Vapes Bill debate and aims to ensure pouches remain accessible as safer alternatives for smokers.
Oct.28 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
South Korea to ban vape vending machines near schools from February 15, 2026
South Korea to ban vape vending machines near schools from February 15, 2026
Starting from February 15, 2026, South Korea bans e-cigarette vending machines within 200m of schools to protect youth from nicotine products.
Oct.14 by 2FIRSTS.ai
Two Malaysian Men Charged Over Illegal Import of  Vape Items at Singapore Checkpoint
Two Malaysian Men Charged Over Illegal Import of Vape Items at Singapore Checkpoint
Two Malaysian men arrested for illegally importing e-cigarettes at Woodlands Checkpoint, facing charges, court hearing on December 15. (20 words)
Nov.18 by 2FIRSTS.ai
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Philip Morris Bangladesh Limited (PMBL) has received approval to invest USD 5.82 million in a nicotine pouch factory in Narayanganj. Regulators say the project is legal under existing laws, while health groups argue it breaches a 2016 Supreme Court order and poses youth addiction risks.
Nov.07 by 2FIRSTS.ai